VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...

VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a ...

A Gemini cationic surfactant was synthesized through an aldehyde-amine condensation reaction to address challenges related to bacterial corrosion and foaming during shale gas extraction. This ...

Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

Gene-based therapy is crucial in treating various disorders and diseases by conferring genetic material to target cells. Calcium phosphate (Ca-P) nanoparticles show promise as a non-viral vector for ...

In this webinar, learn how advanced nanoparticle characterization improves formulation stability, product quality, and ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

Process characterization and viral clearance validation are pivotal studies in biopharmaceutical manufacturing, particularly for monoclonal antibodies (mAbs) produced in mammalian systems, which carry ...

Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...

Advanced liposome engineering services help researchers improve drug targeting, stability, and controlled release for ...

The stability of lisinopril in an extemporaneously prepared suspension stored at or below 25 °C for 28 days under ambient light exposure was studied. A formulation of 1-mg/mL oral suspension was ...

VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...